Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.
about
Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer.Lysophospholipids in coronary artery and chronic ischemic heart disease.Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD.Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol effluxAmbient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites.Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE-/- mice.Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease.Giardia's primitive GPL biosynthesis pathways with parasitic adaptation 'patches': implications for Giardia's evolutionary history and for finding targets against Giardiasis.Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunum.ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural Remodeling.Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.JNK1 Mediates Lipopolysaccharide-Induced CD14 and SR-AI Expression and Macrophage Foam Cell Formation.Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
P2860
Q35822272-3CA98951-FA9E-45DE-9233-553E0EF6F258Q36198168-5D46187B-AA3F-4FE1-BFCA-000523BFCF9DQ36843312-9EE8926C-EF42-4A61-B741-D5A9ECDDB897Q37033119-32B6FEB2-F5D3-4ECE-BC34-6FB410A927B0Q37648540-9B229041-B253-40F6-B05A-D5613D640441Q37698833-7CB174B3-F14C-42DE-A4D6-480D6E4708ECQ38903367-83E5C7E9-0B75-47C7-A361-0CB95690CCA4Q41534334-79545E2E-BEA1-4DB1-8B65-EE1EE759410AQ42879444-F0F7EDAA-8F4A-4CCA-9207-D05169F42516Q47708481-F2E2C058-48F7-419D-B271-666C66852E78Q48268746-25C6406E-9E99-4655-90B0-987F17430CA0Q49240567-ACD322E7-D6CF-4085-9E95-9E50C95ACC5CQ52640499-BB41CA97-D5A7-4A5C-AD7E-DFCAF47ABC87
P2860
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Source and role of intestinall ...... lipidemia and atherosclerosis.
@ast
Source and role of intestinall ...... lipidemia and atherosclerosis.
@en
type
label
Source and role of intestinall ...... lipidemia and atherosclerosis.
@ast
Source and role of intestinall ...... lipidemia and atherosclerosis.
@en
prefLabel
Source and role of intestinall ...... lipidemia and atherosclerosis.
@ast
Source and role of intestinall ...... lipidemia and atherosclerosis.
@en
P2093
P2860
P356
P1476
Source and role of intestinall ...... lipidemia and atherosclerosis.
@en
P2093
Alan C Wagner
Alan M Fogelman
Arnab Chattopadhyay
David Meriwether
G M Anantharamaiah
Greg Hough
Kym F Faull
Lin H Hwang
Mohamad Navab
P2860
P304
P356
10.1194/JLR.M056614
P577
2015-02-02T00:00:00Z